Results 61 to 70 of about 155,199 (206)

Cutaneous lupus erythematosus after treatment with paclitaxel and bevacizumab for metastatic breast cancer: a case report

open access: yesJournal of Medical Case Reports, 2011
Introduction The monoclonal anti-vascular endothelial growth factor antibody bevacizumab is increasingly used in the treatment of several malignant tumors. The usual side effects of this drug are hypertension and proteinuria. Paclitaxel is widely used in
Koulu Leena   +4 more
doaj   +1 more source

Characteristics of Cutaneous Lupus Erythematosus Patients in Dermatology and Venereology Outpatient Clinic

open access: yesBerkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology)
Background: Cutaneous lupus erythematosus (CLE) is a specific skin manifestation of lupus erythematosus. This condition can be accompanied by systemic involvement that affect patient therapy and prognosis. The characteristics of CLE patients in Indonesia
Nyoman Suryawati   +3 more
doaj   +1 more source

Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus.

open access: yesJournal of Autoimmunity, 2021
Q. Lu   +34 more
semanticscholar   +1 more source

Autologous Fat Transfer in a Patient with Lupus Erythematosus Profundus

open access: yesCase Reports in Dermatology, 2012
Lupus erythematosus profundus, a form of chronic cutaneous lupus erythematosus, is a rare inflammatory disease involving in the lower dermis and subcutaneous tissues. It primarily affects the head, proximal upper arms, trunk, thighs, and presents as firm
Jimi Yoon   +5 more
doaj   +1 more source

Indexes of skin activity and damage in patients with systemic lupus erythematosus – CLASI and R-CLASI

open access: yesНаучно-практическая ревматология
Introduction. Cutaneous Lupus Disease Area and Severity Index (CLASI) and its modified version, the Revised Cutaneous Lupus Erythematosus Disease Areas and Severity Index (R-CLASI) are tools for quantifying skin and mucosal lesions in patients with both ...
А. А. Shumilova   +4 more
doaj   +1 more source

Rapid clearance of cutaneous lesions with anifrolumab in SLE (systemic lupus erythematosus) and DLE (discoid lupus erythematosus)

open access: yesJEADV Clinical Practice
Background Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple organs, including the skin. Activation of the Type I interferon pathway is a key pathophysiological factor in SLE. Discoid lupus erythematosus (DLE) is a chronic
E. Parriel   +7 more
doaj   +1 more source

Successful use of anifrolumab in refractory cutaneous lupus erythematosus with systemic lupus erythematosus: A case report

open access: yesSAGE Open Medical Case Reports
A 61-year-old female with systemic lupus erythematosus presented with refractory discoid lupus. Despite treatment with numerous immunosuppressive therapies, including prednisone, hydroxychloroquine and mycophenolate mofetil, her cutaneous lupus remained ...
Abdullah Ramadhan   +3 more
doaj   +1 more source

[Systemic lupus erythematosus: cutaneous/articular injuries].

open access: yesRevista da Associação Médica Brasileira, 2006
Sociedade Brasileira de Reumatologia
semanticscholar   +1 more source

Current Insights Into The Management Of Discoid Lupus Erythematosus

open access: yesClinical, Cosmetic and Investigational Dermatology, 2019
Jaime Company-Quiroga,* Sergio Alique-García,* Alberto Romero-MatéDermatology Department, Fuenlabrada Univesity Hospital, Madrid, Spain*These authors contributed equally to this workCorrespondence: Jaime Company-QuirogaDermatology ...
Company-Quiroga J   +2 more
doaj  

Lupus erythematosus tumidus: clinical perspectives

open access: yesClinical, Cosmetic and Investigational Dermatology, 2019
Nikolaos Patsinakidis,1,2 Ocko Kautz,1 Bernhard F Gibbs,2 Ulrike Raap1,2 1University Clinic of Dermatology and Allergology, University of Oldenburg, Klinikum Oldenburg Aör, Oldenburg, Germany; 2Division of Experimental Allergy and Immunodermatology,
Patsinakidis N   +3 more
doaj  

Home - About - Disclaimer - Privacy